Active Ingredient(s): Bendamustine Hydrochloride
FDA Approved: * December 7, 2015
Pharm Company: * EAGLE PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bendeka Overview

Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma.[2][3] It is given by injection into a vein.[2] Common side effects include low blood cell counts, fever, nausea, diarrhea, loss of appetite, cough, and rash.[2] Other severe side effects include allergic reactions and increased risk of...

Read more Bendeka Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Bendeka Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bendamustine Hydrochloride
  • Injection: 100 Mg/m2, 100mg, 100mg/4ml (25mg/ml), 100mg/vial, 25mg
  • Powder: 100mg/vial, 25mg/vial
  • Solution: 100mg/4ml (25mg/ml), 180mg/2ml (90mg/ml), 45mg/0.5ml (90mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bendeka: (1 result)

Sorted by National Drug Code
  • 63459-348 Bendeka 25 mg/ml Intravenous Injection, Solution by Teva Pharmaceuticals USA, Inc.

Other drugs which contain Bendamustine Hydrochloride or a similar ingredient: (2 results)